Shows
Hariçten SanatSevil Tunaboylu'yla 16. Sharjah Bienali için hazırladığı sanatçı kitabı üzerine16. Sharjah Bienali için yeni yapıtlar üreten ve sanatçı kitabı yayımlanan Sevil Tunaboylu ile bir araya geliyoruz. 2025-03-1726 min
Hariçten SanatSevil Tunaboylu'yla 16. Sharjah Bienali için hazırladığı sanatçı kitabı üzerine16. Sharjah Bienali için yeni yapıtlar üreten ve sanatçı kitabı yayımlanan Sevil Tunaboylu ile bir araya geliyoruz.2025-03-1726 min
Cinayet MasasıCinayet Masası - İnci Küpeli Kadınlar#cinayetmasası
📚
5 eski karısına da şiddet uygulamış, hepsine inci küpe hediye edip “Cenazemde tak” diye vasiyet etmiş bir adam...
Sevin Okyay, polisiye yazarı Armağan Tunaboylu’yla yeni romanını konuşuyor: “İnci Küpeli Kadınlar”.2024-12-1619 min
Bizim Bedenimiz41.bölüm - kadın bedeninde doğal süreçler [menstrüasyon] #4Bizim Bedenimizde kadın bedeninin doğal süreçlerini mercek altına aldığımız seride menstrüasyonu konuşmaya devam ediyoruz. Bu bölümde çoğunlukla doğru bilinen yanlışlar ve az bilinenlerden bahsettik; regl kanının muhteviyatının ne olduğu ve bu kanın pis olmadığını; bu kanı pis addedenlerin kim oldukları ve kadınların bu söylemi, tutumu içselleştirmesini nasıl açıklayabileceğimizi; herkesin regl döngüsünün bedenine ve ruh haline farklı yansımaları olduğunu; regl olmanın kadınları neden mutsuz ettiğini; "başka bir menstrüasyonun mümkün...2024-11-2029 min
Bizim Bedenimiz40.bölüm - kadın bedeninde doğal süreçler [menstrüasyon] #3Kadın bedeninin doğal süreçlerini konuştuğumuz serinin menstrüasyon ayağına geldik. Bu serinin ilk bölümünde kısaca kelimenin etimolojisi; biyolojik tanımı ve kimlerin âdet gördüğü; regl olmanın ergenlik çağındaki bir kız çocuğunun gelişimi üzerinde ne tür fizyolojik etkileri olduğu; regl olmanın ortalama yaş aralıkları; kanama tipi ve sıklıklarının neye göre şekillendiği; bir âdet döngüsüne ne zaman düzensiz dediğimiz; bunun üzerindeki genetik ve dış faktörlerin etkisi, bu işin “normali” olup olmadığı; ağrı/sancı eşiğinin hangi...2024-11-1328 min
Future of Drug DiscoveryMurat Tunaboylu - Antiverse: Engineering the Future of Drug Discovery (FODD #8)Are you curious about the latest advancements in AI-enabled antibody discovery? In this podcast series, we dive into the world of Antiverse - we are accelerating drug discovery against difficult targets, including GPCRs and ion channels, using machine learning and phage display techniques.
Join us as we discuss our mission to target cancer, cardiovascular disease, and other challenging conditions. Discover how we leverage AI and wet lab innovation to accelerate the discovery and development of biologics. Plus, learn about our unique approach to antibody discovery, our progress with our internal pipeline of antibodies against GPCRs and other...2024-09-0927 min
Future of Drug DiscoveryBen Holland - Machine Learning-Based Design of Antibodies Against Difficult Targets (FODD #9)In this captivating podcast series, we dive deep into the world of computational antibody discovery with Ben Holland, our Co-Founder and CTO at Antiverse. Join us as we uncover the immense potential of merging computational and experimental techniques in the pursuit of revolutionary antibodies, as Ben sheds light on the strong benefits and formidable challenges encountered when targeting complex molecules such as GPCRs. With an emphasis on precision and accuracy in predicting antibody-antigen interactions, Ben shares remarkable insights and breakthroughs achieved by computational discovery techniques. Tune in and join us at the forefront of antibody discovery!
...2024-09-0926 min
Future of Drug DiscoveryTzvika Hartman - Reimagining Therapeutic Antibodies Using AI (FODD #10)In this talk, Murat speaks with Tzvika Hartman, Senior Vice President of Computation at Biolojic Design, a company curating AI-designed antibodies focused on autoimmune diseases and immuno-oncology applications.
Biolojic uses machine learning to design 'programmable' antibodies with more precise molecular effects. These antibodies work dynamically with their environment, both temporally and spatially, opening avenues for new ways to alter biology. Their lead candidate, AU-007, pioneered by spin-out company Aulos Bioscience, is being advanced through Phase II clinical studies in solid tumour cancers.
Don't miss this exciting opportunity to learn about the technology and strategies at Bi...2024-09-0923 min
Future of Drug DiscoveryAbhishek Pandey - Machine Learning Blueprints for Pharma Discovery Breakthroughs (FODD #11)In this talk, Murat speaks with Abhishek Pandey, Principle Research Scientist and Pharma Discovery Group Lead at AbbVie.
Abhishek currently leads RAIDERS, a Pharma Discovery group integrating machine learning across all of AbbVie's working groups to augment drug discovery capabilities. Abhishek's groups work spans cheminformatics, imaging research, multi-omics, as well as the computation behind many of AbbVie's current partnerships and collaborations.
We'll be exploring how the machine learning group is transforming the processes across multiple working groups at the pharmaceutical giant, AbbVie. We'll also be unravelling the story of how A...2024-09-0927 min
Future of Drug DiscoveryRahmad Akbar - Frontiers of AI Antibody Design (FODD #17)This episode is a discussion between Rahmad Akbar, Senior Data Scientist in Antibody Design at Novo Nordisk and Murat Tunaboylu, Co-Founder and CEO of Antiverse.
You will learn:
The impact antibody design has on the world.
How AI is helping to push antibody design forward, bringing new therapies to patients.
What will antibody design look like in the future?
Rahmad's LinkedIn page.
Rahmad's Personal Website.
Antibody Origami: Here.
Rahmad's Previous and Existing Team: Victor Greiff (GreiffLab). Paolo Marcatili, Ludovica Beltrame, Rasmus Høiberg-Nielsen (Antibody Design at Novo No...2024-09-0326 min
Future of Drug DiscoveryPaul Essery and Murat Tunaboylu - Founding an AI Drug Discovery Start-Up (FODD #16)This episode is a discussion between Paul Essery, Host of 'The Tech Business Podcast' and Murat Tunaboylu Co-Founder and CEO of Antiverse.
You will learn:
The CEO journey and how Antiverse was founded.
How artificial intelligence is solving challenging targets in antibody discovery.
Successes and challenges of being a biotech founder (+advice for aspiring entrepreneurs).
Be sure to like, rate and/or review the podcast if you enjoyed it!
Visit our website: https://www.antiverse.io/
Follow us:
2024-07-2314 min
Future of Drug DiscoveryBjörn Schimmöller - Inorganic Chemistry at the Frontier of Immunotherapy (FODD #15)In this episode, we speak with Björn Schimmöller, Co-Founder and CEO of iuvantium, a synthetic immunobiology company developing new modalities for the next generation of immunotherapies.
Host: Murat Tunaboylu, Co-Founder and CEO of Antiverse.
You will learn:
The founding journey of iuvantium from Oxford University.
How Iuvantium is enhancing immune system efficiency and reducing clinical trial uncertainty using inorganic chemistry.
‘Decoding’ the immune system and how personalised medicine may lead to the next leaps in immunotherapy.
Things mentioned:
AstraZeneca COVID-19 vaccine
John Austyn - CSO and Co-Founder of Iuvantium
Ralph Steinman
Farooq Khan...2024-01-1722 min
Dr. GPCR Podcast#136 - Murat Tunaboylu & Ben HollandWatch the video version of this podcast episode.
-------------------------------------------
Become a #DrGPCR Ecosystem Member
-------------------------------------------
Imagine a world in which the vast majority of us are healthy.
The #DrGPCR Ecosystem is all about dynamic interactions between us working towards exploiting the druggability of # GPCRs. We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
-------------------------------------------
To build our #GPCR Ecosystem, we created various enabling outlets.
Individuals
Organizations
-------------------------------------------
Are you a #GPCR professional?
Subscribe to #DrGPCR Monthly Newsletter
Listen and subscribe to #DrGPCR Podcasts
Listen and watch GPCR-focused scientific talks at #VirtualCafe.
2023-12-1449 min
Future of Drug DiscoveryAshwini Ghogare - AI, Automation and Drug Discovery (FODD #14)In this episode, we speak with Ashwini Ghogare, Head of Artificial Intelligence and Automation in Drug Discovery at MilliporeSigma, the Global Science and Technology Group at Merck.
Host: Murat Tunaboylu, Co-Founder and CEO of Antiverse.
You will learn:
About Ashwini’s journey to her current role.
How to bridge the gaps between working groups with different skill sets for optimal computational drug discovery.
The interplay between AIDDISON™ and SYNTHIA™ to automate the drug discovery process.
The industry's critical requirements for progress in the AI drug discovery space.
Things mentioned:
MELLODDY
AIDDISON™: Harnessing Generative AI to Revolutionize Dr...2023-12-1126 min
Future of Drug DiscoveryMing 'Tommy' Tang - Unleashing the Power of Computational Biology (FODD #13)In this talk, Murat speaks with Ming (Tommy) Tang, Director of Computational Biology at Immunitas Therapeutics, an immuno-oncology start-up developing novel therapeutics for patients with cancer.
Tommy is a strong leader and communicator in the field of computational biology. He has dedicated his life's work to accelerating cancer research, with prominent expertise in analysing large-scale bulk sequencing data, single-cell and spatial transcriptomic data and epigenetic data.
Outside of his career at Immunitas, Tommy is a brilliant science communicator and teacher, with various educational streams, including Twitter, a blog, a GitHub r...2023-10-2033 min
Future of Drug DiscoveryNikhil Reddy Podduturi - Digital Foundations For Rapid Healthcare Advancement (FODD #12)In this talk, Murat speaks with Nikhil Podduturi, Head of Data Science at the Digital Lab of Boehringer Ingelheim - (BI X).
Nikhil co-leads the laboratory and data science chapters at the BI X headquarters in Germany and China. The team at BI X is pioneering digital innovations to improve the lives of patients and animals. The current technologies developed by BI X include PetPro Connect, Farmera, and Pathological Speech Processing, with impacts spanning multiple healthcare fields.
Nikhil's current work involves developing new tools to accelerate drug discovery with advanced genetic sequencing technologies, designing new in silico system...2023-10-0627 min
Sonsuz Çilek TarlalarıEskiz ile söyleşiGeçen Kasım ayında "Ateşle Beni" adlı son albümünü yayınlayan ve 15 senelik yolculuğunu sonlandırdığını duyuran Eskiz grubuyla, 14 Nisan'da verecekleri son konserleri öncesinde tam kadro buluştuk.Yakın müzik tarihimizde önemli bir yer tutan tüm üretimleri için Eskiz’e teşekkür ve güzel bir veda mahiyetindeki bu özel bölümde Deniz Ağan, Can Tunaboylu ve Uygar Çetiner’le ilk günlerinden bugüne Eskiz’in uzun yolculuğunu, bu yolculuktaki temel köşe taşlarını, Ekşi Limon’dan Peyote’ye, Roxy Müzik Günleri’nden yurt dışı festivalleri...2023-04-1040 min
Future of Drug DiscoveryAlan Nafiiev - Receptor AI - Membranotropic Drug Discovery (FODD #7)In this episode, we speak with Alan Nafiiev, Co-Founder and CEO of ‘RECEPTOR.AI’, an Artificial Intelligence (AI)-drug discovery company focused on screening small drug molecule candidates against difficult-to-drug targets.
Alan gives some key insights into the history of Receptor AI, the company's successes and obstacles, and how Receptor AIs 'software as a service' (SaaS) and services are streamlining the drug discovery process for pharmaceutical and biotech companies. He also discusses how Receptor AIs technology can automate and customise drug discovery pipelines.
To conclude, Alan explains Receptor AIs plans for 2023 - branching into membranotropic drug...2023-03-0731 min
Future of Drug DiscoveryTom Fleming - Better Data Today. Better Drugs Tomorrow (FODD #6)Arctoris COO Tom Fleming talks about automation and building a small molecule discovery platform2022-10-1631 min
Cinayet Masası - Sevin Okyay'la polisiye romanPolisiye Yazarının ÖlümüArmağan Tunaboylu, yeni kitabında okuyucuyu farklı bir kahramanla tanıştırıyor; titiz komiser Berkun İstanbullu!
'Polisiye Yazarının Ölümü' Sevin Okyay ile #CinayetMasası'nda...2022-05-2925 min
Cinayet MasasıCinayet Masası - Polisiye Yazarının ÖlümüArmağan Tunaboylu, yeni kitabında okuyucuyu farklı bir kahramanla tanıştırıyor; titiz komiser Berkun İstanbullu!
'Polisiye Yazarının Ölümü' Sevin Okyay ile #CinayetMasası'nda...2022-05-2926 min
Future of Drug DiscoveryTim Jenkins - AI Bites Back! (FODD #5)In this episode, our guest Assistant Prof. Tim Jenkins talks about snakebites and how to use AI to design broadly neutralising antibodies against venoms. Tim takes us through his experience at Milner Therapeutics Institute and shares his passion and vision for connecting academia and startups/industry players. In the second half of this talk, Tim explains the complexity in the venom domain and the challenges that lie ahead for the commercialisation of antivenom antibodies.
PS: Recently, with InstaDeep, Tim has posed a snake antivenom challenge as part of the largest hackathon in Africa.
2022-04-0131 min
Future of Drug DiscoveryAndrew Martin - abYsis and Antibody Developability (FODD #4)In episode 4, Murat talks with Andrew C. R. Martin, Professor of Bioinformatics and Computational Biology at UCL, about abYsis (a fully integrated antibody discovery system) and the latest antibody developability tools!
Following the origin story of abYsis, you will hear the differences between the public and commercial versions such as data persistence and security, as well as new tools such as abYmod and abYdraw.
At the end of the talk, the discussion moves into developability (stability and Immunogenicity).
Antiverse - Engineering the future of drug discovery - https://www.antiverse.io/
To...2022-03-1441 min
Future of Drug DiscoveryKonrad Krawczyk - Natural Antibody (Antibody Datasets and ML) (FODD #3)Future of Drug Discovery Episode #3
In this session, Murat talks with Konrad Krawczyk, Assistant Professor SDU and Founder of NaturalAntibody.
We will be covering Mr Natural Antibody's views on developing and using bioinformatics tools to analyse and discover biologics.
Other topics in this episode:
- Changing role of bioinformatics from assisting to being the main driver in biologics discovery
- 99% of the job is to get quality data, 1% is computational methods
- Collecting data from Patents, Scientific Publications, NGS, Therapeutics from FDA
- Developing models for binding prediction and b...2022-03-0632 min
Future of Drug DiscoveryRyan Kelly - 100+ discovery campaigns against challenging targets (FODD #2)In this episode, Murat talks with Ryan Kelly about Abveris (employee #3) and how to run 100+ discovery campaigns against challenging targets.2022-02-1732 min
Future of Drug DiscoveryVictor Greiff - Immunology and Machine Learning Applied to Drug Discovery (FODD #1)FODD 1 - Victor Greiff - Immunology and Machine Learning Applied to Drug Discovery2022-02-0529 min
Learning With LowellMurat Tunaboylu Founder Antiverse 2 Year Raise, Hiring Distributed Team, and ML/AI in biotech -122This episodes breaks those clichés a part and shows the truth that grit and perseverance can get you. It is a great update on Murat and how ML/AI in biotech can change the world. Additionally, Murat has been on the show before as well so it's exciting to see what he has been up to for the last few years.2021-07-2758 minStories – Learning with LowellMurat Tunaboylu Founder Antiverse 2 Year Raise, Hiring Distributed Team, and ML/AI in biotech -122This episodes breaks those clichés a part and shows the truth that grit and perseverance can get you. It is a great update on Murat and how ML/AI in biotech can change the world. Additionally, Murat has been on the show before as well so it's exciting to see what he has been up to for the last few years.
The post Murat Tunaboylu Founder Antiverse 2 Year Raise, Hiring Distributed Team, and ML/AI in biotech -122 first appeared on Learning with Lowell.2021-07-2758 minVenture capital – Learning with LowellMurat Tunaboylu Founder Antiverse 2 Year Raise, Hiring Distributed Team, and ML/AI in biotech -122This episodes breaks those clichés a part and shows the truth that grit and perseverance can get you. It is a great update on Murat and how ML/AI in biotech can change the world. Additionally, Murat has been on the show before as well so it's exciting to see what he has been up to for the last few years.
The post Murat Tunaboylu Founder Antiverse 2 Year Raise, Hiring Distributed Team, and ML/AI in biotech -122 first appeared on Learning with Lowell.2021-07-2758 mintechnology – Learning with LowellMurat Tunaboylu Founder Antiverse 2 Year Raise, Hiring Distributed Team, and ML/AI in biotech -122This episodes breaks those clichés a part and shows the truth that grit and perseverance can get you. It is a great update on Murat and how ML/AI in biotech can change the world. Additionally, Murat has been on the show before as well so it's exciting to see what he has been up to for the last few years.
Source2021-07-2758 minfounder – Learning with LowellMurat Tunaboylu Founder Antiverse 2 Year Raise, Hiring Distributed Team, and ML/AI in biotech -122This episodes breaks those clichés a part and shows the truth that grit and perseverance can get you. It is a great update on Murat and how ML/AI in biotech can change the world. Additionally, Murat has been on the show before as well so it's exciting to see what he has been up to for the last few years.
Source2021-07-2758 minscientist – Learning with LowellMurat Tunaboylu Founder Antiverse 2 Year Raise, Hiring Distributed Team, and ML/AI in biotech -122This episodes breaks those clichés a part and shows the truth that grit and perseverance can get you. It is a great update on Murat and how ML/AI in biotech can change the world. Additionally, Murat has been on the show before as well so it's exciting to see what he has been up to for the last few years.
The post Murat Tunaboylu Founder Antiverse 2 Year Raise, Hiring Distributed Team, and ML/AI in biotech -122 first appeared on Learning with Lowell.2021-07-2758 min
Şimdi Karşıya GeçebilirsinizEmre Hüner: “Fare Çağırıcının Malzeme Listesi”Arter Öğrenme Programı, Emre Hüner’in Arter’de devam eden [ELEKTROİZOLASYON]: Bilinmeyen Parametre Kayıt-Dışı başlıklı kişisel sergisi bağlamında bir podcast serisi yayımlıyor.
Üç bölümden oluşan bu podcast serisi, serginin üretim süreçlerinde farklı mekânlarda alınan ses kayıtları, radyo haberleri, Meliha Erem’in Hipernotlar başlıklı kısa öykülerinden kesitler ve [ELEKTROİZOLASYON] adlı filmin seslendirmelerinden derlenmiş yeni ses kolajlarına yer veriyor.
Seslendirenler: Deniz Koloğlu, Esme Madra, Cem Özeren, Sevil Tunaboylu
Kayıt: Emir Kazak
Müzik ve Montaj: Emre Hüner
S...2021-06-1806 min
Şimdi Karşıya GeçebilirsinizEmre Hüner: “Reality Şov”Arter Öğrenme Programı, Emre Hüner’in Arter’de devam eden [ELEKTROİZOLASYON]: Bilinmeyen Parametre Kayıt-Dışı başlıklı kişisel sergisi bağlamında bir podcast serisi yayımlıyor.
Üç bölümden oluşan bu podcast serisi, serginin üretim süreçlerinde farklı mekânlarda alınan ses kayıtları, radyo haberleri, Meliha Erem’in Hipernotlar başlıklı kısa öykülerinden kesitler ve [ELEKTROİZOLASYON] adlı filmin seslendirmelerinden derlenmiş yeni ses kolajlarına yer veriyor.
Seslendirenler: Deniz Koloğlu, Esme Madra, Cem Özeren, Sevil Tunaboylu
Kayıt: Emir Kazak
Müzik ve Montaj: Emre Hüner
S...2021-06-1806 min
Şimdi Karşıya GeçebilirsinizEmre Hüner: "Şizoelektrik"Arter Öğrenme Programı, Emre Hüner’in Arter’de devam eden [ELEKTROİZOLASYON]: Bilinmeyen Parametre Kayıt-Dışı başlıklı kişisel sergisi bağlamında bir podcast serisi yayımlıyor.
Üç bölümden oluşan bu podcast serisi, serginin üretim süreçlerinde farklı mekânlarda alınan ses kayıtları, radyo haberleri, Meliha Erem’in Hipernotlar başlıklı kısa öykülerinden kesitler ve [ELEKTROİZOLASYON] adlı filmin seslendirmelerinden derlenmiş yeni ses kolajlarına yer veriyor.
Seslendirenler: Deniz Koloğlu, Esme Madra, Cem Özeren, Sevil Tunaboylu
Kayıt: Emir Kazak
Müzik ve Montaj: Emre Hüner
S...2021-06-1706 min
Major Ring Experience#35 - Murat Tunaboylu - CEO of AntiverseMurat Tunaboylu is co-founder of Antiverse - the biotech startup speeding up the drug discovery process from years to weeks 2021-05-0514 min
Bant Mag.Bant Mag. Radyo: Eskiz ve "Kozmik Ruh Dansı" albümüDeniz Ağan, Can Tunaboylu ve Uygar Çetiner’den oluşan Eskiz, eylül sonunda yayımladığı Kozmik Ruh Dansı albümüyle hem işitsel hem yapısal anlamda kendini tazeledi. Yine 60’lar rock’n’roll referansları olsa da albümün önceki Eskiz kayıtlarına nazaran daha parlak ve daha coşkulu bir atmosferi var. Prodüktörlüğünü Alp Ersönmez’in üstlendiği ve bağımsız olarak yayımlanan albümü, Eskiz üyelerinden dinledik.
2020-10-2830 min
Bant Mag. RadyoBant Mag. Radyo: Eskiz ve "Kozmik Ruh Dansı" albümüDeniz Ağan, Can Tunaboylu ve Uygar Çetiner’den oluşan Eskiz, eylül sonunda yayımladığı Kozmik Ruh Dansı albümüyle hem işitsel hem yapısal anlamda kendini tazeledi. Yine 60’lar rock’n’roll referansları olsa da albümün önceki Eskiz kayıtlarına nazaran daha parlak ve daha coşkulu bir atmosferi var. Prodüktörlüğünü Alp Ersönmez’in üstlendiği ve bağımsız olarak yayımlanan albümü, Eskiz üyelerinden dinledik.2020-10-2830 min
I love towa bird podcastsleepwalk guitar improv - towa bird2020-08-1004 min
I love towa bird podcastredbone guitar improv cover - towa (1)2020-08-1002 min
I love towa bird podcastless i know the better guitar cover - towa2020-08-1003 min
I love towa bird podcastall along the watchtower guitar cover - towa bird2020-08-1001 min
I love towa bird podcastadore you cover - towa bird2020-08-1008 min
I love towa bird podcastlazy jam 1 - towa bird2020-08-1003 min
I love towa bird podcastfireflies guitar cover - towa bird2020-08-1000 min
I love towa bird podcastjuicy cover - towa bird2020-08-1004 min
I love towa bird podcastslow dancing in a burning room cover - towa bird2020-08-1003 min
I love towa bird podcastsay no more - towa bird2020-08-1001 min
TellyCast: The TV industry podcastEpisode 12 - Viasat World's Seniha Tunaboylu & Eccho Rights' Nicola SoderlundHead of Content and Acquisitions at Viasat World Seniha Tunaboylu and Eccho Rights' Managing Partner Nicola Soderlund join host and founder of Boom! PR Justin Crosby to discuss the latest news in the global TV industry including market events including this year's MIPCOM and Banijay's Endemol Shine takeover. And we’ll find out who their Heroes of the Week are – and who or what they'll be telling to Get in the Bin!Deadline Hollywood's Peter White brings us up to date on production rest...2020-07-0956 minLearning With Lowell40: Computational Antibody Drug Discovery Platform with Machine Learning Startup, Antiverse, with the Co-Founder Murat TunaboyluMachine Learning, Antibodies, and Drug discovery.
Antiverse is building a world-first computational antibody drug discovery platform. We combine in-house lab expertise with state of the art machine learning to predict antibody-antigen binding and provide antibody drug candidates in one day. Source
Click here for the quick text interview we had:
Quick Text Interview with Murat Co-Founder of Antiverse An AI Antibody Drug Discovery Platform
Website
Contact info: info@antiverse.io
"Antiverse: Leveraging AI to Achieve Antibody Drug Discovery in One Day
BETTER MEDICINES FASTER
Antiverse is building a world-first computational antibody drug discovery platform to predict antibody-antigen binding and provide a...2018-06-2631 min
Açık DergiAçık Dergi: 24 Mayıs 2017_Bize Ait Bir OdaArzu Yayıntaş ve Sevil Tunaboylu ile Ark Kültür'de açılan Bize Ait Bir Oda'yı konuştuk. 2017-05-2427 minAçık DergiAçık Dergi: 24 Mayıs 2017_Bize Ait Bir OdaArzu Yayıntaş ve Sevil Tunaboylu ile Ark Kültür'de açılan Bize Ait Bir Oda'yı konuştuk.2017-05-2427 minGünün ve Güncelin EdebiyatıGünün ve Güncelin Edebiyatı: (20 Ekim 2016)Konuğumuz: Armağan Tunaboylu2016-11-0825 min
Günün ve Güncelin EdebiyatıArgo, dil ve polisiye: Armağan Tunaboylu'yla söyleşiArmağan Tunaboylu, 1960 yılında Eskişehir'de doğdu. Ortaokul ve lise öğrenimini İstanbul'da, Galatasaray Lisesi'nde okuduktan sonra, İzmir'de sinema-tv öğrenimi gördü. Okulun ardından İstanbul'a dönerek kısa bir süre gazetecilik yaptı. Daha sonra çeşitli televizyon şirketlerinde ve dizilerde görev aldı. Yıldız Cinayetleri, Resi Cinayetleri, Konsey Cinayetleri ve Karakol Cinayetleri adlı eserleri vardır.2016-10-2025 min
ACMI Stories & IdeasAIDC 2016 Patchwork Commisioning PodcastWith tough local TV market conditions and the influence of globalisation on the film and television industry, 'patchwork' financing has become a way for producers to secure financing by cobbling together multiple markets and platforms. But in order to successfully finance and secure multiple deals, it is important to understand these international marketplaces and manage the expectations of multiple deals.
This session explores the issues around managing stakeholder expectations and the pressure of keeping everyone happy; issues around delivering one offs vs multiple versions; and issues around different languages, tones and styles as well as cultural and historic differences.
Speakers: E...2016-05-101h 20Açık Dergi2 Haziran 2015: Sevil Tunaboylu / Aklımda2 Haziran 2015: Sevil Tunaboylu / Aklımda Açık Dergi'de ressam Sevil Tunaboylu ile Sanatorium'da açılan "Aklımda" başlıklı sergisi ve hafızanın mekânı, mekânın hafızası hakkında sohbet etmek üzere buluştuk.2015-06-0521 minAçık Dergi2 Haziran 2015: Sevil Tunaboylu / Aklımda2 Haziran 2015: Sevil Tunaboylu / Aklımda Açık Dergi'de ressam Sevil Tunaboylu ile Sanatorium'da açılan "Aklımda" başlıklı sergisi ve hafızanın mekânı, mekânın hafızası hakkında sohbet etmek üzere buluştuk.2015-06-0500 minAçık Dergi11 Ocak 2013: Sevil Tunaboylu: Ufukta Kabolana Kadar İzledimAçık Dergi'de "Ufukta Kaybolana Kadar İzledim" başlıklı sergisini konuşmak üzere Sevil Tunaboylu'yu konuk ettik. Sevil Tunaboylu'yla Çanakkale Bienali'ndeki yerleştirmesinin bir saldırıya uğrayarak tahrip edilmesi ve sanatçının bundan çok geç haberinin olmasına ve küratörlerin tavrına dair de konuştuk.2013-01-1423 minAçık Dergi11 Ocak 2013: Sevil Tunaboylu: Ufukta Kabolana Kadar İzledimAçık Dergi'de "Ufukta Kaybolana Kadar İzledim" başlıklı sergisini konuşmak üzere Sevil Tunaboylu'yu konuk ettik. Sevil Tunaboylu'yla Çanakkale Bienali'ndeki yerleştirmesinin bir saldırıya uğrayarak tahrip edilmesi ve sanatçının bundan çok geç haberinin olmasına ve küratörlerin tavrına dair de konuştuk.2013-01-1406 min